167 related articles for article (PubMed ID: 12713628)
21. [Detection of p16 by fluorescence in-situ hybridization and immunohistochemistry in malignant mesothelioma].
Liu Y; Chen X; Ding N; Xu W; Yang H; Chen X
Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):262-5. PubMed ID: 25975910
[TBL] [Abstract][Full Text] [Related]
22. [Pathology of primary tumours of the pleura].
Junker K; Krismann M
Zentralbl Chir; 2008 Jun; 133(3):222-6. PubMed ID: 18563685
[TBL] [Abstract][Full Text] [Related]
23. Myogenic antigen expression is useful for differentiation between epithelioid mesothelioma and non-neoplastic mesothelial cells.
Tsukiji H; Takeshima Y; Amatya VJ; Kushitani K; Inai K
Histopathology; 2010 Jun; 56(7):969-74. PubMed ID: 20636799
[No Abstract] [Full Text] [Related]
24. The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesothelioma.
Attanoos RL; Gibbs AR
Histopathology; 2008 Sep; 53(3):340-4. PubMed ID: 18647189
[TBL] [Abstract][Full Text] [Related]
25. [Morphological diagnostics of malignant pleural mesothelioma].
Junker K; Müller KM
Pathologe; 2014 Nov; 35(6):586-90. PubMed ID: 25304423
[TBL] [Abstract][Full Text] [Related]
26. The separation of benign and malignant mesothelial proliferations.
Churg A; Colby TV; Cagle P; Corson J; Gibbs AR; Gilks B; Grimes M; Hammar S; Roggli V; Travis WD
Am J Surg Pathol; 2000 Sep; 24(9):1183-200. PubMed ID: 10976692
[TBL] [Abstract][Full Text] [Related]
27. The differential diagnosis of epithelial-type mesothelioma from adenocarcinoma and reactive mesothelial proliferation.
Soosay GN; Griffiths M; Papadaki L; Happerfield L; Bobrow L
J Pathol; 1991 Apr; 163(4):299-305. PubMed ID: 2033489
[TBL] [Abstract][Full Text] [Related]
28. Differential diagnosis of reactive mesothelial cells and malignant mesothelioma cells using the cell proliferation markers minichromosome maintenance protein 7, geminin, topoisomerase II alpha and Ki-67.
Kimura F; Okayasu I; Kakinuma H; Satoh Y; Kuwao S; Saegusa M; Watanabe J
Acta Cytol; 2013; 57(4):384-90. PubMed ID: 23860238
[TBL] [Abstract][Full Text] [Related]
29. Benign pleural lesion and malignant mesothelioma.
Klima M; Gyorkey F
Virchows Arch A Pathol Anat Histol; 1977 Nov; 376(3):181-93. PubMed ID: 145715
[TBL] [Abstract][Full Text] [Related]
30. p53 expression is common in malignant mesothelioma.
Kafiri G; Thomas DM; Shepherd NA; Krausz T; Lane DP; Hall PA
Histopathology; 1992 Oct; 21(4):331-4. PubMed ID: 1398535
[TBL] [Abstract][Full Text] [Related]
31. Comparison of silver-staining nucleolar organizer region (AgNOR) counts and proliferating cell nuclear antigen (PCNA) expression in reactive mesothelial hyperplasia and malignant mesothelioma.
Bethwaite PB; Delahunt B; Holloway LJ; Thornton A
Pathology; 1995 Jan; 27(1):1-4. PubMed ID: 7603742
[TBL] [Abstract][Full Text] [Related]
32. D2-40 and calretinin - a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation.
Hinterberger M; Reineke T; Storz M; Weder W; Vogt P; Moch H
Mod Pathol; 2007 Feb; 20(2):248-55. PubMed ID: 17361207
[TBL] [Abstract][Full Text] [Related]
33. [Malignant mesothelioma of the pleura. Morphometric study].
Serio G; Caniglia DM; Pennella A; Giardina C; Dalena AM; Serio R; Lettini T; Ricco R
Pathologica; 1997 Apr; 89(2):122-7. PubMed ID: 9411357
[TBL] [Abstract][Full Text] [Related]
34. [Thoracoscopic anatomy, significance of pathologic findings in thoracoscopic open lung biopsy, and pleural mesothelioma].
Kawai T; Watanabe M; Takagi K
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Dec; 32 Suppl():142-7. PubMed ID: 7602822
[TBL] [Abstract][Full Text] [Related]
35. Malignant mesothelioma eight years after a diagnosis of atypical mesothelial hyperplasia.
Scurry J; Duggan MA
J Clin Pathol; 1999 Jul; 52(7):535-7. PubMed ID: 10605410
[TBL] [Abstract][Full Text] [Related]
36. Interpretation of pleural biopsy specimens and aspirates with the immunoperoxidase technique.
Herbert A; Gallagher PJ
Thorax; 1982 Nov; 37(11):822-7. PubMed ID: 6761889
[TBL] [Abstract][Full Text] [Related]
37. Malignant mesothelioma with heterologous elements: clinicopathological correlation of 27 cases and literature review.
Klebe S; Mahar A; Henderson DW; Roggli VL
Mod Pathol; 2008 Sep; 21(9):1084-94. PubMed ID: 18587319
[TBL] [Abstract][Full Text] [Related]
38. Benign Pleural Mesothelial Cells Have Higher Osmotic Water Permeability than Malignant Pleural Mesothelioma Cells and Differentially Respond to Hyperosmolality.
Katkova LE; Baturina GS; Bondar AA; Jagirdar RM; Hatzoglou C; Gourgoulianis KI; Solenov EI; Zarogiannis SG
Cell Physiol Biochem; 2019; 52(4):869-878. PubMed ID: 30958661
[TBL] [Abstract][Full Text] [Related]
39. Utility of glucose transporter 1 in the distinction of benign and malignant thoracic and abdominal mesothelial lesions.
Lagana SM; Taub RN; Borczuk AC
Arch Pathol Lab Med; 2012 Jul; 136(7):804-9. PubMed ID: 22742553
[TBL] [Abstract][Full Text] [Related]
40. Cytologic Differential Diagnosis of Malignant Mesothelioma and Reactive Mesothelial Cells With FISH Analysis of p16.
Hiroshima K; Wu D; Hasegawa M; Koh E; Sekine Y; Ozaki D; Yusa T; Walts AE; Marchevsky AM; Nabeshima K; Tada Y; Shimada H; Tagawa M
Diagn Cytopathol; 2016 Jul; 44(7):591-8. PubMed ID: 27079839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]